C

CMG Pharmaceutical Co Ltd
KOSDAQ:058820

Watchlist Manager
CMG Pharmaceutical Co Ltd
KOSDAQ:058820
Watchlist
Price: 1 799 KRW -1.75% Market Closed
Market Cap: 266B KRW

Relative Value

The Relative Value of one CMG Pharmaceutical Co Ltd stock under the Base Case scenario is hidden KRW. Compared to the current market price of 1 799 KRW, CMG Pharmaceutical Co Ltd is hidden .

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

CMG Pharmaceutical Co Ltd Relative Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
87
vs Industry
39
Median 3Y
3.2
Median 5Y
3.6
Industry
2.6
vs History
vs Industry
3
Median 3Y
47.7
Median 5Y
64.5
Industry
21.4
vs History
vs Industry
12
Median 3Y
38.5
Median 5Y
79.6
Industry
16.4
vs History
47
vs Industry
29
Median 3Y
14.3
Median 5Y
13.9
Industry
22.8
vs History
90
vs Industry
51
Median 3Y
1.5
Median 5Y
1.6
Industry
2.2
vs History
87
vs Industry
45
Median 3Y
2.8
Median 5Y
3
Industry
2.9
vs History
95
vs Industry
38
Median 3Y
5.7
Median 5Y
6.2
Industry
5.5
vs History
vs Industry
14
Median 3Y
46.2
Median 5Y
52.2
Industry
13
vs History
vs Industry
9
Median 3Y
73.1
Median 5Y
96.8
Industry
16.5
vs History
vs Industry
15
Median 3Y
33.4
Median 5Y
66.1
Industry
15.6
vs History
vs Industry
Median 3Y
-12.1
Median 5Y
-25.7
Industry
18.7
vs History
95
vs Industry
57
Median 3Y
1.4
Median 5Y
1.8
Industry
1.9

Multiples Across Competitors

Competitors Multiples
CMG Pharmaceutical Co Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
KR
CMG Pharmaceutical Co Ltd
KOSDAQ:058820
264.9B KRW 2.8 -14.7 -119 -41.3
US
Eli Lilly and Co
NYSE:LLY
997.6B USD 16.8 54.2 36.4 39
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
US
Johnson & Johnson
NYSE:JNJ
494.8B USD 5.4 19.7 16.1 20.9
CH
Roche Holding AG
SIX:ROG
263.6B CHF 4.3 28 11.9 13.9
UK
AstraZeneca PLC
LSE:AZN
218.4B GBP 5.1 31.5 109.5 160.2
CH
Novartis AG
SIX:NOVN
214.5B CHF 4.8 18.8 11.9 15.4
US
Merck & Co Inc
NYSE:MRK
270.7B USD 4.2 14.2 10.1 12
DK
Novo Nordisk A/S
CSE:NOVO B
1.6T DKK 5.2 15.7 11 12.7
IE
Endo International PLC
LSE:0Y5F
213.9B USD 92.2 -73.2 338.7 849.2
US
Pfizer Inc
NYSE:PFE
146.1B USD 2.3 14.9 7.6 10.3
P/E Multiple
Earnings Growth PEG
KR
C
CMG Pharmaceutical Co Ltd
KOSDAQ:058820
Average P/E: 24.6
Negative Multiple: -14.7
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
54.2
54%
1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A N/A
US
Johnson & Johnson
NYSE:JNJ
19.7
29%
0.7
CH
Roche Holding AG
SIX:ROG
28
29%
1
UK
AstraZeneca PLC
LSE:AZN
31.5
37%
0.9
CH
Novartis AG
SIX:NOVN
18.8
17%
1.1
US
Merck & Co Inc
NYSE:MRK
14.2
15%
0.9
DK
Novo Nordisk A/S
CSE:NOVO B
15.7
3%
5.2
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -73.2 N/A N/A
US
Pfizer Inc
NYSE:PFE
14.9
27%
0.6
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
KR
C
CMG Pharmaceutical Co Ltd
KOSDAQ:058820
Average EV/EBITDA: 439.9
Negative Multiple: -119
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
36.4
34%
1.1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
3 846.3
36%
106.8
US
Johnson & Johnson
NYSE:JNJ
16.1
9%
1.8
CH
Roche Holding AG
SIX:ROG
11.9
5%
2.4
UK
AstraZeneca PLC
LSE:AZN
109.5
10%
10.9
CH
Novartis AG
SIX:NOVN
11.9
6%
2
US
Merck & Co Inc
NYSE:MRK
10.1
6%
1.7
DK
Novo Nordisk A/S
CSE:NOVO B
11
1%
11
IE
E
Endo International PLC
LSE:0Y5F
338.7
N/A N/A
US
Pfizer Inc
NYSE:PFE
7.6
0%
N/A
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
KR
C
CMG Pharmaceutical Co Ltd
KOSDAQ:058820
Average EV/EBIT: 1 883.6
Negative Multiple: -41.3
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
39
36%
1.1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
17 702.3
98%
180.6
US
Johnson & Johnson
NYSE:JNJ
20.9
15%
1.4
CH
Roche Holding AG
SIX:ROG
13.9
6%
2.3
UK
AstraZeneca PLC
LSE:AZN
160.2
23%
7
CH
Novartis AG
SIX:NOVN
15.4
12%
1.3
US
Merck & Co Inc
NYSE:MRK
12
8%
1.5
DK
Novo Nordisk A/S
CSE:NOVO B
12.7
0%
N/A
IE
E
Endo International PLC
LSE:0Y5F
849.2
N/A N/A
US
Pfizer Inc
NYSE:PFE
10.3
7%
1.5